Sickle Cell Disease Visiting Professorship Program Grant

Sickle Cell Disease Visiting Professorship Program Grant

Status: ACTIVE
Funder: Pfizer, Inc.
Amount: Up to US $15,000
Last Updated: May 13, 2025

Summary

The Sickle Cell Disease Visiting Professorship Program aims to provide crucial financial support for organizations lacking SCD-focused resources. It facilitates the hosting of a Visiting Professor with expertise tailored to address educational gaps in Sickle Cell Disease management. This initiative encourages robust interaction between experts and local healthcare providers, enhancing their knowledge and establishing coordinated care beyond acute services. Priority is given to institutions ready to engage actively with the expert during educational exchanges.

Overview

Overview This competitive program seeks to provide financial support to organizations with limited SCD-focused resources and experience to host and coordinate a medical education program at their organization. The program should be led by a Visiting Professor of their choosing with expertise matched to the organization’s unmet educational needs surrounding the management of Sickle Cell Disease. Project Types and Area of Interest It is our intent to support opportunities for an institution to host a Sickle Cell Disease healthcare provider expert (”Expert„) to foster educational exchanges with local healthcare providers who can benefit from the Expert‚s knowledge and on-site presence.Expert should focus on educating Host Institution to establish coordinated care for individuals living with sickle cell disease beyond acute care service.Applicants should highlight educational gaps and describe how the selected Expert will address them during the visit.Priority will be given to plans that include robust opportunities for the Expert to interact with healthcare providers at the host organization beyond the lecture format. The organization responding to this posting and requesting the grant funding should be the organization ready to identify, invite, and host the Expert.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Application Details

Pfizer Independent Medical Education
Grant Request for Proposals
Competitive Grant Program —Pfizer Internal Review Process
Sickle Cell Disease Visiting Professorship Program
Overview
This competitive program seeks to provide financial support to
organizations with limited SCD-focused resources and experience to host
and coordinate a medical education program at their organization. The
program should be led by a Visiting Professors of their choosing with
expertise matched to the organization‚s unmet educational needs
surrounding the management of Sickle Cell Disease.
Geographic Scope/Location of Project
United States
Project Types and Area of Interest
• It is our intent to support opportunities for an institution to host a
Sickle Cell Disease healthcare provider expert (”Expert„) to foster
educational exchanges with local healthcare providers who can benefit
from the Expert‚s knowledge and on-site presence.
• Expert should focus on educating Host Institution to establish
coordinated care for individuals living with sickle cell disease beyond
acute care service.
• Applicants should highlight educational gaps and describe how the
selected Expert will address them during the visit.
• Priority will be given to plans that include robust opportunities for the
Expert to interact with healthcare providers at the host organization
beyond the lecture format. The organization responding to this posting
and requesting the grant funding should be the organization ready to
identify, invite, and host the Expert.
Key Milestones
Anticipated Grant
Anticipated Project
Submission Deadline Award Notification
Start Date
June 12, 2025 July 2025 On or after
August 2025
Funding Range and Project Length
Individual projects requesting up to $15,000 will be considered.
Pfizer anticipates awarding up to 3-5 grants.

I. Eligibility
Geographic Scope/Location of Project/Study
• United States
Applicant Eligibility Criteria
• The following may apply: medical and/or nursing professional schools; healthcare institutions (both
large and small); professional organizations/medical societies; and other entities with a mission
related to healthcare professional education and/or healthcare improvement.
• Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an
independent group of physicians not affiliated with a hospital, academic institution, or professional
society).
• If the project involves multiple departments within an institution and/or between different institutions
/organizations/associations, all institutions must have a relevant role and the requesting organization
must have a key role in the project.
• The applicant must be the project/program lead or an authorized designee of such individual (e.g.,
project/program lead‚s grant coordinator).
• The project/program lead must be an employee or contractor of the requesting organization.
• For projects offering continuing education credit, the requesting organization must be accredited.
II. Requirements
Primary Area of Interest
• Sickle Cell Disease
General Area of Interest for this RFP
• It is our intent to support opportunities for an institution to host a Sickle Cell Disease medical expert (”Expert„) to
foster educational exchanges with local healthcare providers who can benefit from the Expert‚s knowledge and on-
site presence.
• Expert should focus on educating Host Institution to establish coordinated care for individuals living with sickle cell
disease beyond acute care service.
• Applicants should highlight educational gaps and describe how the selected Expert will address them during the
visit.
• Priority will be given to host health systems and institutions with limited SCD-focused resources and experience.
• Proposals should include robust opportunities for the Expert to interact with healthcare providers at the host
organization beyond the lecture format. The organization responding to this posting and requesting the grant
funding should be the organization ready to identify, invite, and host the Expert.
It is not our intent to support clinical research projects. Projects evaluating the eĔ cacy of therapeutic or
diagnostic agents will not be considered.
Target Audience
• Healthcare teams providing care to young adults/adults living with sickle cell disease
2

Expected Approximate Monetary Range of Grant Applications:
• Individual projects requesting up to $15,000 will be considered, to cover expenses such as logistical
management, Expert travel and honoraria. Pfizer anticipates awarding 3-5 grants.
• Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy),
and indirect costs.
• The amount of the grant Pfizer will be prepared to fund for any project will depend upon the expert
review panel‚s evaluation of the proposal and costs involved and will be stated clearly in the grant
agreement.
Timeline
Anticipated Grant Anticipated Project
RFP Release Date Award Notification End Date
March 10, 2025 July 2025 Before July 2026
Submission Deadline* Anticipated Project
Start Date
June 12, 2025
August 2025
IMPORTANT: Be advised applications submitted after the due date will not be reviewed.
* Please note the deadline is 23:59 Eastern Standard Time (e.g., New York, GMT -5).
III. Submissions
How to Submit
IMPORTANT: Please read this section carefully since applications submitted not following these
instructions will not be accepted and will be cancelled.
• Please go to w w w . c y b e r g r a n t s . c o m / p f i z e r / k n o w l e d g e and sign in.
• Note: there are individual portals for each grant application type. Please be sure to use the URL
above.
• First-time users should click ”Create your password„.
• Click the button "Start a New Knowledge Gap Application".
• Requirements for submission:
• Complete all required sections of the online application and upload your project proposal
(see Appendix) in the General RFP Submission field.
• If you encounter any technical difficulties with the website, please click the ”Technical Questions„ link at
the bottom of the page.
• In the application:
… For the question ”Competitive Grant?„ select ”Yes„
• Select the following Primary Area of Interest: Genetics - Sickle Cell Disease KG
• Select the following Competitive Grant Program Name: 2025 RD US SCD Visiting Professorship
3

Questions
• If you encounter any technical difficulties with the website, please click here or the ”Technical
Questions„ link at the bottom of the page in the grant submission system.
• Please click here to view ”Frequently Asked Questions„ regarding the Competitive Grant Program.
• If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Amanda
Stein (amanda.j.stein@pfizer.com), with the subject line ”SCD Visiting Professorship.„
Mechanism by which Applicants will be notified
• All applicants will be notified via email by the dates noted above.
• Applicants may be asked for additional clarification during the review period.
Review and Approval Process
• Grant requests received in response to a general RFP are reviewed by Pfizer to make final grant
decisions.
Grant Agreements
• If your grant is approved, your institution will be required to enter into a written grant agreement with
Pfizer. Please click here to view the core terms of the agreement.
• Under Pfizer's competitive grant program, modifications to grant agreements will not be reviewed
unless a genuine conflict exists as between applicable law and the terms of the relevant grant
agreement. Applicant is encouraged to share the core terms with counsel for approval prior to
submitting an application.
• Except where prohibited by applicable law and, in any case, subject to review by Pfizer Legal, payment
of grant funding may only be paid to the grantee organization.
About Pfizer Global Medical Grants & Partnerships
Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community‚s
independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes
in areas of unmet medical need that are aligned with Pfizer‚s medical and/or scientific strategies.
Pfizer‚s GMGP competitive grant program involves a publicly posted general Request for Proposal (RFP)
that provides detail regarding a general area of interest, sets timelines for review and approval, and uses
an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an
application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is
responsible for the design, implementation, and conduct of the independent initiative supported by the
grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the
independent education program.
References
• Druye AA, Agyare DF, Akoto-Buabeng W, Zutah J, Offei FO, Nabe B, Ofori GO, Alhassan A, Anumel BK,
Cobbinah G, Abraham SA, Amoadu M, Hagan JE Jr. Healthcare Professionals' Knowledge, Attitudes,
and Practices in the Assessment, and Management of Sickle-Cell Disease: A Meta-Aggregative Review.
Diseases. 2024 Jul 14;12(7):156. doi: 10.3390/diseases12070156. PMID: 39057127; PMCID:
PMC11276276.
4

Appendix
IMPORTANT: RFP Submission Requirements
Applications will be accepted via the online portal listed in the How to Submit section. Project Proposals
should be single-spaced using Calibri 12-point font and 1-inch margins. Note there is a 15-page limit
exclusive of references. When uploading your Project Proposal please ensure it addresses the following
sections:
Goals and Objectives
• Briefly state the overall goal of the project.
• List the objectives you plan to meet with your project, in terms of learning and expected outcomes.
Needs Assessment for the Project
• Include a description of your organization‚s needs assessment for this proposed project which may
include a quantitative baseline data summary, initial metrics, or a project starting point (please cite
data on gap analyses or relevant patient-level data that informs the stated objectives) in your target
area.
Target Audience
• Describe the primary audience(s) targeted for this project. Indicate whom you believe will directly
benefit from the project outcomes. Describe the overall population size as well as the size of your
sample population.
Project Design and Methods
• Describe the planned project, the educational approach, and the way the planned methods address
the established need.
Innovation
• Explain what measures you have taken to assure that this project is original and does not duplicate
other projects or materials already developed. Describe how this project builds upon existing work,
pilot projects, or ongoing projects developed either by your institution or other institutions.
Evaluation and Outcomes
• In terms of the metrics used for the needs assessment, describe how your organization will determine
if the gap was addressed for the target group. Identify the sources of data your organization
anticipates using to make the determination. Describe how your organization is expected to collect
and analyze the data. Explain the method used to control for other factors outside this project (e.g.,
use of a control group or comparison with baseline data). Quantify the amount of change expected
from this project in terms the target audience. Describe how your organization will determine if the
target audience was fully engaged in the project.
Dissemination Plan
• Describe how the project may have extended benefit beyond the grant. Will the teaching materials be made
available to others to use? Will there be tools or resources that are made publicly available beyond the
initial project. Describe how the project outcomes might be broadly disseminated.
Anticipated Project Timeline
• Provide an anticipated timeline for your project including project start/end dates.
Additional Information
• If there is any additional information you feel Pfizer should be aware of concerning the importance of
this project, please summarize here.
5

Organization Detail
• Describe the attributes of the institutions / organizations / associations that will support and facilitate
the execution of the project and the leadership of the proposed project. Articulate the specific role of
each partner in the proposed project.
Budget Detail
• Please include a budget narrative that describes in greater detail the line items specified in the budget
submitted within the application.
• Funding is to be used to cover the Expert‚s honorarium, travel expenses, and other direct expenses
incurred by host organization in conducting program activities. No portion of a Pfizer independent
grant will be used to support food or beverages for learners/participants associated with an activity or
initiative. Note this also includes organization faculty attending Visiting Professorship programs. All
grant recipient organizations will be required to certify during reconciliation that funds were not used
for food and/or beverages for learners/participants in any capacity
• Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer. Please
click here for details. General organizational running costs such as legal fees, insurance, heating and
lighting etc. should be included in an Institutional Overhead (if required). These costs are not specific
to a grant request and therefore, should not appear as line items in budgets.
Required Documents
• Project Plan/Proposal or Meeting Agenda
• Letter of support from Hosting institution
6